<?xml version="1.0" encoding="UTF-8"?>
<p>To open-up niche space and decrease graft rejection, newborn or adult mice can be preconditioned prior engraftment through sublethal irradiation [
 <xref rid="B14-vaccines-08-00036" ref-type="bibr">14</xref>,
 <xref rid="B17-vaccines-08-00036" ref-type="bibr">17</xref>,
 <xref rid="B245-vaccines-08-00036" ref-type="bibr">245</xref>,
 <xref rid="B307-vaccines-08-00036" ref-type="bibr">307</xref>] or antibody-pretreatment [
 <xref rid="B313-vaccines-08-00036" ref-type="bibr">313</xref>,
 <xref rid="B314-vaccines-08-00036" ref-type="bibr">314</xref>,
 <xref rid="B315-vaccines-08-00036" ref-type="bibr">315</xref>]. However, HIS mouse models, capable of reaching high levels of human immune reconstitution without the need of preconditioning, have been recently described [
 <xref rid="B15-vaccines-08-00036" ref-type="bibr">15</xref>,
 <xref rid="B262-vaccines-08-00036" ref-type="bibr">262</xref>]. 
</p>
